This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thomas, J. Articles by Grossman, D. Search for Related Content PubMed PubMed Citation Articles by Thomas, J. Articles by Grossman, D.

Melanocyte Expression of Survivin Promotes Development and Metastasis of UV-Induced Melanoma in HGF-Transgenic Mice

¹ Huntsman Cancer Institute; Departments of ² Dermatology and ³ Oncological Sciences, and Melanoma Program, University of Utah Health Science Center, Salt Lake City, Utah

Requests for reprints: Douglas Grossman, Huntsman Cancer Institute, Suite 5243, 2000 Circle of Hope, Salt Lake City, UT 84112. Phone: 801-581-4682; Fax: 801-585-0900; E-mail: doug.grossman{at}hci.utah.edu.

We previously found the apoptosis inhibitor Survivin to be expressed in melanocytic nevi and melanoma but not in normal melanocytes. To investigate the role of Survivin in melanoma development and progression, we examined the consequences of forced Survivin expression in melanocytes in vivo. Transgenic (Tg) mouse lines (Dct-Survivin) were generated with melanocyte-specific expression of Survivin, and melanocytes grown from Dct-Survivin mice expressed Survivin. Dct-Survivin melanocytes exhibited decreased susceptibility to UV-induced apoptosis but no difference in proliferative capacity compared with melanocytes derived from non-Tg littermates. Induction of nevi in Dct-Survivin and non-Tg mice by topical application of 7,12-dimethylbenz(a)anthracene did not reveal significant differences in lesion onset (median, 10 weeks) or density (4 lesions per mouse after 15 weeks). Dct-Survivin mice were bred with melanoma-prone MH19/HGF-B6 Tg mice, and all progeny expressing either individual, neither, or both (Survivin/HGF) transgenes were UV-treated as neonates and then monitored for 43 weeks. Melanocytes in neonatal Survivin⁺/HGF⁺ mouse skin were less susceptible to UV-induced apoptosis than those from Survivin^–/HGF⁺ mice. Onset of melanocytic tumors was earlier (median, 18 versus 24 weeks; P = 0.01, log-rank test), and overall tumor density was greater (7.7 versus 5.2 tumors per mouse; P = 0.04) in Survivin⁺/HGF⁺ compared with Survivin^–/HGF⁺ mice. Strikingly, melanomas arising in Survivin⁺/HGF⁺ mice showed a greater tendency for lymph node (35% versus 0%; P = 0.04) and lung (53% versus 22%) metastasis and lower rates of spontaneous apoptosis than those in Survivin^–/HGF⁺ mice. These studies show a role for Survivin in promoting both early and late events of UV-induced melanoma development in vivo. [Cancer Res 2007;67(11):5172–8]

This article has been cited by other articles:

				D. J. McCrann, T. Yezefski, H. G. Nguyen, N. Papadantonakis, H. Liu, Q. Wen, J. D. Crispino, and K. Ravid Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice Blood, April 15, 2008; 111(8): 4092 - 4095. [Abstract] [Full Text] [PDF]

				D. Raj, T. Liu, G. Samadashwily, F. Li, and D. Grossman Survivin repression by p53, Rb and E2F2 in normal human melanocytes Carcinogenesis, January 1, 2008; 29(1): 194 - 201. [Abstract] [Full Text] [PDF]

				M. A. Cotter, J. Thomas, P. Cassidy, K. Robinette, N. Jenkins, S. R. Florell, S. Leachman, W. E. Samlowski, and D. Grossman N-Acetylcysteine Protects Melanocytes against Oxidative Stress/Damage and Delays Onset of Ultraviolet-Induced Melanoma in Mice Clin. Cancer Res., October 1, 2007; 13(19): 5952 - 5958. [Abstract] [Full Text] [PDF]